Vol. XXVI · No. 04 · Apr 2026
Peritia
The Right Expert. Right Now.
FEATURE · THE FRACTIONAL THESIS

Every week without the right expert is a week your program does not move.

Peritia is rewiring how life sciences programs access the specialists they need — in 48 hours, not 48 days. An editorial on the end of the long hire.

The full-time hire used to be the answer. A Series B biotech facing a Phase 3 protocol gap would post a role, interview for ten weeks, onboard for six, and — if they were lucky — see a productive month before the readout deadline. That math no longer pencils out. Peritia is the counter-model: a pre-vetted network of 4,000-plus specialists, matched to the shape of the problem inside 48 hours, paid for the work and not the headcount. The thesis is simple. The execution is the moat. And the clients — 335 of them, across 20 countries — are telling the same story back to us, in different words. Speed is the product. Specificity is the proof. The 48-hour promise is the line that every other offer bends to meet.

The six products. One network.

The outcomes, filed.

CLINICAL · PHASE 3
Phase 3 Ops Lead placed in 6 days.
6d
Series B · Oncology · Mar 2026
REGULATORY · BLA
BLA strategist inside agency in 72 hours.
72hr
Mid-Pharma · Feb 2026
EVIDENCE · HEOR
HEOR dossier team assembled in three markets.
Specialty Pharma · Jan 2026
COMMERCIAL · LAUNCH
Launch readiness lead scoped in one week.
1wk
Gene Therapy · Nov 2025
STRATEGY · PRE-IPO
Investor-readiness advisor placed pre-S1.
14d
Series C · Oct 2025
TALENT · INTERIM
Interim CMO seated through approval.
9mo
Clinical-Stage · Ongoing
CLINICAL · GLOBAL
Monitor team scaled across 14 countries.
14×
Phase 3 · Cardiovascular
REGULATORY · CMC
CMC gap closed ahead of pre-IND.
30d
Early Biotech · Sep 2025
EDITOR'S NOTE

Stop hiring by job description.
Start hiring by outcome.

The match is free. The 48-hour promise is real. The first conversation is with a human who's been through this before.